Related Experiment Video
Updated: May 21, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Migration-linked TB epidemics: How TB elimination in high-income countries depends on the success of TB control in
Byron L M Cohen1,2, Kevin Croke1, William P Hanage3
1Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA 02115.
Abstract:
Mycobacterium tuberculosis is the leading global cause of infectious disease deaths. A growing proportion of tuberculosis cases in high-income countries occur among foreign-born individuals, due to infections acquired before migration. We developed a system of mathematical models representing tuberculosis epidemiology in 187 countries, linked by migration patterns, and trained on empirical data for each setting. Using these models, we quantified how future tuberculosis risks in high-income countries are influenced by the success or failure of efforts to combat tuberculosis in high-burden settings. Over 2025-2050, we projected 2270,000 (95%CI: 1930,000 to 2730,000) tuberculosis cases in high-income countries if pre-2025 trends continue, with 54% (46 to 62) among foreign-born individuals (versus 39% in 2024), for an average incidence of 6.0 (4.8 to 7.7) per 100,000 in 2050. Under the most optimistic scenario (assuming high-burden countries achieve aggressive WHO tuberculosis elimination targets), we estimated 667,000 (559,000 to 812,000) fewer tuberculosis cases in high-income countries over 2025-2050, with incidence of 2.6 (2.1 to 3.3) per 100,000 in 2050. Under the most pessimistic scenario (reduced international health aid causes rising tuberculosis in high-burden countries), we estimated 890,000 (793,000 to 998,000) additional tuberculosis cases in high-income countries, with incidence of 10.2 (8.4 to 12.7) per 100,000 in 2050. The United States, United Kingdom, Germany, Singapore, and France were the most affected high-income countries. For high-income countries, future tuberculosis incidence and mortality could vary by as much as 4 times depending on the success or failure of tuberculosis control in high-burden settings, fundamentally shaping strategies to prevent, detect, and treat tuberculosis in these settings.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Infectious Diseases and Their Occurrence
